Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
about
Exercise or exercise and diet for preventing type 2 diabetes mellitusTreatment of prediabetesTherapeutic Use of Metformin in Prediabetes and Diabetes PreventionEvaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in SingaporePrevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.Lifestyle change in Kerala, India: needs assessment and planning for a community-based diabetes prevention trial.Evaluation of lifestyle interventions to treat elevated cardiometabolic risk in primary care (E-LITE): a randomized controlled trial.A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Björknäs study.Blood glucose testing and primary prevention of diabetes mellitus type 2--evaluation of the effect of evidence based patient information.Prevalence of diagnosed diabetes in an urban area of Puducherry, India: Time for preventive action.Cost-effectiveness analysis of voglibose for prevention of type 2 diabetes mellitus in Japanese patients with impaired glucose toleranceShort and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherenceHolistic approach to prevention and management of type 2 diabetes mellitus in a family setting.Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 diabetes pharmacogenetic testingThe cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study.Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular riskTranslating physical activity interventions for breast cancer survivors into practice: an evaluation of randomized controlled trialsScreening adults for pre-diabetes and diabetes may be cost-saving.Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review.Naturopathic medicine and type 2 diabetes: a retrospective analysis from an academic clinicEconomic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults.Canadian Physicians' Use of Antiobesity Drugs and Their Referral Patterns to Weight Management Programs or Providers: The SOCCER Study.Effects of enhanced depression treatment on diabetes self-careThe economics of diabetes prevention.The effect of self-care education program on reducing HbA1c levels in patients with type 2 diabetesCluster randomised controlled trial of a peer-led lifestyle intervention program: study protocol for the Kerala diabetes prevention program.Changes in health state utilities with changes in body mass in the Diabetes Prevention Program.Effective intervention of self-care on glycaemia control in patients with type 2 diabetes.An update on the Diabetes Prevention ProgramEconomic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.Delaying the onset of type 2 diabetes mellitus in patients with prediabetes.Medication costs during an 18 month clinical trial of obesity treatment among patients encountered in primary care.Improving health outcomes with better patient understanding and education.The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.Research aimed at improving both mood and weight (RAINBOW) in primary care: A type 1 hybrid design randomized controlled trial.Dosage effects of diabetes self-management education for Mexican Americans: the Starr County Border Health Initiative.Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer.Cardiometabolic Risk Factor Changes Observed in Diabetes Prevention Programs in US Settings: A Systematic Review and Meta-analysisA lifestyle program of exercise and weight loss is effective in preventing and treating type 2 diabetes mellitus: Why are programs not more available?
P2860
Q24241914-F8B94FB3-4E20-43FC-8F3F-85DC6E06EFABQ26783350-DD578001-7B28-4EB9-993F-D85CB35DA315Q26822066-134434C9-929F-43B4-82D7-620E90CC6EBEQ28542893-9DD63514-9147-4BC2-909E-BE1038DC4FC7Q30393802-F65C3981-AD56-4B48-B042-083C35AA593FQ30536305-4E7B7194-797A-4C77-9AD4-38DC1E8847E1Q30883786-4E1FA8D3-34B8-4EFC-BEBC-54C55B1F098EQ33430008-D766B79F-0B33-4448-ADA9-25DFAE03088EQ33523883-F803CEB4-9E30-4096-A665-B4739E5D4A84Q33574378-656C74D1-0ACD-4D81-92F7-46BF905F1516Q33585487-33269002-5D56-437E-9F35-4AEBFEBD3BB8Q33589814-5C39E1F7-987A-420E-8298-A8F490B85F74Q33706603-E1529304-A59C-4C6C-ADB4-9755FF5FE4CEQ33779389-4126EBA5-4F96-427B-8C27-293B5CF55895Q33801995-D487400A-CD26-46D4-8F6B-1ABF3650B214Q33813768-3DDECE8A-9C79-4C84-A697-D97871DDCF65Q33878538-AC570D05-E535-444C-B8D2-80B7DA679925Q33932674-C2016102-E18B-41C7-9035-EFF1AE0E7512Q34016162-873236DD-6D88-4E86-A4F0-F8BD8420EC0EQ34146656-D338E261-BE9E-40E1-B16C-4C12B081EB3EQ34196906-2BDFC49F-DE35-4CC3-9861-7FFBAE811116Q34237357-CAB8A9CE-0D9A-45BF-8999-EE242B0B6F11Q34339129-E5AB2EE6-7A6B-4FFB-8277-5DE533884725Q34490125-B61BA31C-115C-4A92-819F-7FAA717CC556Q34700621-D9D7CB57-58DC-4ADE-9ECA-4D708DF0F168Q34767422-C5EAEB9D-9C8F-4025-BBBF-47E6C6336888Q35030240-B828C6EF-CE1B-454B-B999-8B59840F3870Q35101304-B5038ECC-F496-4896-AC24-ED12DD8E4F7CQ35123878-90FAEF7E-333F-4E8E-B26E-2F357D07BB14Q35568874-AE742596-EE18-44B9-BD3B-3E3C6D1FCB7BQ35689542-1B5DDEC5-02EE-4908-86D9-AAF3BC367DE0Q35709779-C3DCFE42-0540-4895-B25A-B285ED8D4486Q35718705-5D0937D6-D134-4171-A050-D4686049AEC4Q35727739-08DFEC79-94AE-496E-97AF-5F35E56F3589Q35841138-F163455C-2C36-4C1C-8084-2C2B1765C4BBQ35957450-C2D7B035-643F-438E-A8D5-B1AA5862AA52Q36013448-4C0D32AD-3581-4794-8BB3-DE5C0E5FF283Q36035997-5C4C2E42-2CF5-4493-8776-B98EDDC44537Q36086147-F80E8603-5AE2-40D6-A784-9A4A6A72749CQ36090083-34A29935-C03A-44E1-8B03-81542E87236C
P2860
Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Within-trial cost-effectivenes ...... prevention of type 2 diabetes.
@ast
Within-trial cost-effectivenes ...... prevention of type 2 diabetes.
@en
Within-trial cost-effectivenes ...... prevention of type 2 diabetes.
@nl
type
label
Within-trial cost-effectivenes ...... prevention of type 2 diabetes.
@ast
Within-trial cost-effectivenes ...... prevention of type 2 diabetes.
@en
Within-trial cost-effectivenes ...... prevention of type 2 diabetes.
@nl
prefLabel
Within-trial cost-effectivenes ...... prevention of type 2 diabetes.
@ast
Within-trial cost-effectivenes ...... prevention of type 2 diabetes.
@en
Within-trial cost-effectivenes ...... prevention of type 2 diabetes.
@nl
P2860
P1433
P1476
Within-trial cost-effectivenes ...... prevention of type 2 diabetes.
@en
P2860
P304
P356
10.2337/DIACARE.26.9.2518
P407
P577
2003-09-01T00:00:00Z